Takara Bio Inc.'s market cap is currently ¥118.85B. The company's EPS TTM is ¥-12.55; its P/E ratio is 203.69; and it has a dividend yield of 1.79%. Takara Bio Inc. is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
